Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting

Heleen J. Bouman, Ankie M. Harmsze, Jochem W. van Werkum, Nicoline J. Breet, Th O. Bergmeijer, Hugo ten Cate, Christian M. Hackeng, Vera H. M. Deneer, Jurrien M Ten Berg

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1239-1244
JournalHeart
Volume97
Issue number15
DOIs
Publication statusPublished - Aug 2011

Cite this

Bouman, H. J., Harmsze, A. M., van Werkum, J. W., Breet, N. J., Bergmeijer, T. O., ten Cate, H., Hackeng, C. M., Deneer, V. H. M., & Ten Berg, J. M. (2011). Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting. Heart, 97(15), 1239-1244. https://doi.org/10.1136/hrt.2010.220509